Logo 1 Logo 2

Clinical Trial Details

Trial ID: L1203
Source ID: NCT00297219
Associated Drug: Low Dialysate Calcium
Title: Effects of Lowering Dialysate Calcium Level on Progression of Coronary Artery Calcification and Bone Histomorphometry
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: End-Stage Renal Disease|Hemodialysis
Interventions: DRUG: Low dialysate calcium|DRUG: high dialysate calcium
Outcome Measures: Primary: Progression of coronary artery calcification scores, eighteen months|Changes in bone histomorphometry analysis, eighteen months|Changes in bone mineral density, eighteen months | Secondary: Changes in intact PTH levels, eighteen months|effects of dialysate with or without glucose (e.g intradialytic hypoglycemia and hypotension, arrythmia-by Holter ECG- and changes in HbA1c, insulin), eighteen months
Sponsor/Collaborators: Sponsor: Ege University | Collaborators: University of Kentucky|Fresenius Medical Care North America
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases:
Enrollment: 457
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2005-11
Completion Date: 2008-07
Results First Posted:
Last Update Posted: 2009-08-04
Locations: University of Kentucky Medical Center, Lexington, Kentucky, 40536-0084, United States|FMC Clinics, Bornova, Izmir, Turkey|Ege University School of Medicine, Bornova-Izmir, 35100, Turkey
URL: https://clinicaltrials.gov/show/NCT00297219